about the author

ENDPOINTS

editor@endpointsnews.com

author articles

Fritz Ger­ber, who led Roche for 2 decades, dies; ADC Ther­a­peu­tics tries again for an IPO, sets terms

6 years ago
News Briefing

Ad­verum soars on ear­ly gene ther­a­py da­ta; BerGen­Bio rais­es €45.4M on the heels of Covid-19 move

6 years ago
News Briefing

EMA gives thumbs up to key drugs from No­var­tis, Alex­ion, Ver­tex and more

6 years ago
News Briefing

Ver­tex lav­ish­es $80M cash to ex­pand gene ther­a­py tool kit; Su­per­nus bags a $300M CNS port­fo­lio

6 years ago
News Briefing

As­traZeneca, GSK re­it­er­ate 2020 out­look; Shang­hai biotech I-Mab is look­ing for a US part­ner — re­port

6 years ago
News Briefing

Astel­las part­ners with In­sil­i­co, Har­vard; Zam­bon gets FDA's fast track sta­tus for lung drug

6 years ago
News Briefing

Re­gen­eron/Sanofi PD-1 tri­al halt­ed for sig­nif­i­cant ef­fi­ca­cy; Avadel soars on pos­i­tive nar­colep­sy da­ta

6 years ago
News Briefing

Lau­ra Shawver on why she came back af­ter an $88M wind­fall; Mor­phoSys taps Am­gen vet as CCO

6 years ago
Peer Review

EMA ap­proves Boehringer's sys­temic scle­ro­sis ther­a­py; No­var­tis' Kym­ri­ah wins RMAT sta­tus for fol­lic­u­lar lym­phoma

6 years ago
News Briefing

Sang­amo ties up with a new­com­er in the cell ther­a­py field; Lab­Corp wins FDA au­tho­riza­tion of lat­est Covid-19 test

6 years ago
News Briefing

Sofinno­va Telethon Fund backs Nal­dini's gene ther­a­py biotech; ORIC prices $75M IPO

6 years ago
News Briefing

Covid-19 roundup: HHS of­fi­cial Giroir takes on role of test­ing czar — cue new con­tro­ver­sy; Wuhan lab ve­he­ment­ly ...

6 years ago
Coronavirus

Dorothee Kern’s path from bas­ket­ball star to founder of bil­lion-dol­lar biotech(s?); Five Prime Ther­a­peu­tics hands ...

6 years ago
Peer Review

Gala­pa­gos finds Pol­ish part­ner for in­flam­ma­tion drugs; Zai Lab's Ze­ju­la app gets speedy re­view in Chi­na

6 years ago
News Briefing

Mer­ck launch­es the lat­est Her­ceptin knock­off; Har­vard spin­out grabs a $5M seed round

6 years ago
News Briefing

Al­ny­lam's new pipeline star gets on FDA fast track; ARCH-backed biotech nabs or­phan drug sta­tus

6 years ago
News Briefing

Pfiz­er nabs col­orec­tal can­cer OK for Braftovi; Bris­tol My­ers, Pfiz­er pull out of re­gion­al deal with Por­to­la

6 years ago
News Briefing

Fred­er­ic Pla en­list­ed as COO at the Park­er In­sti­tute; For­mer Alk­er­mes ex­ec named CMO at Seres Ther­a­peu­tics

6 years ago
Peer Review

Covid-19 roundup: Pfiz­er hus­tling up mil­lions of dos­es of vac­cine — de­tails $748M BioN­Tech deal; CDC tweaks stance ...

6 years ago
Coronavirus

Covid-19 roundup: EU‘s top sci­en­tist re­signs in re­buke to agency’s Covid re­sponse; J&J posts neg­a­tive da­ta for ...

6 years ago
Coronavirus

Well­come looks for back­ers of an $8B-plus Covid-19 fund; ReNeu­ron signs on an­oth­er phar­ma part­ner

6 years ago
News Briefing

Covid-19 roundup: Ex-FDA com­mish Got­tlieb joins Re­pub­li­can gov­er­nor's coro­n­avirus team; Phar­ma ap­proval rat­ings ...

6 years ago
Coronavirus

The 20 un­der 40: In­side the next gen­er­a­tion of bio­phar­ma lead­ers

6 years ago
People
Special

GSK vac­cine chief heads for AIDS vac­cine ini­tia­tive; Pfiz­er en­lists Sue Desmond-Hell­mann to its board of di­rec­tors

6 years ago
Peer Review
First page Previous page 12131415161718 Next page Last page
A service from the Financial Times